Atlas Venture

Atlas Venture is a leading biotech venture capital firm.  Atlas companies are custom built to realize their scientific and business potential.

DISCOVER: Identifying true innovation from high-impact science.

DERISK: Proving and maturing the science and technology to guide clinical translation

SHAPE: Crafting the right business model for each opportunity.

STRENGTHEN: Rolling up our sleeves to position our companies for successful drug development and exits in all market environments.

TypeInvestor
HQCambridge, US
Founded1984
Websiteatlasventure.com
Cybersecurity ratingAMore
Atlas Venture was founded in 1984 and is headquartered in Cambridge, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Atlas Venture

Michael Gladstone

Michael Gladstone

Principal
Lisa Huang

Lisa Huang

Associate
Andrea Dimella

Andrea Dimella

Vice President, Head of Talent
Sharon Morani

Sharon Morani

Director of Portfolio Operations
Show more

Atlas Venture Office Locations

Atlas Venture has an office in Cambridge
Cambridge, US (HQ)
400 Technology Square, 400 Technology Square
Show all (1)

Atlas Venture Investment Portfolio

Stage Distribution

20002020

Top Sectors Distribution

20022020

Round Size Distribution

20002020
Show more

Atlas Venture News and Updates

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

CAMBRIDGE, Mass., Sept. 27, 2018 /PRNewswire/ -- Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics, today announced the closing of a $30 million Series A financing led by F-Prime Capital...

Atlas Venture wraps up 11th fund at $350 mln

Cambridge, Massachusetts-based Atlas Venture, an early-stage venture firm, has closed its oversubscribed 11th fund at $350 million. Altas Ventures invests in biotech startups.

Atlas Venture Online and Social Media Presence

Embed Graph

Atlas Venture Blogs

The Vintage of 2020: How COVID-19 is Molding Biotech Startups

It is a strange time to work in the biotech industry. National unemployment has spiked to 11%, the Federal Reserve Bank of Atlanta predicts a 35% drop in US GDP in the second quarter, and yet the XBI index of biotech stocks has risen by more than 20% since the beginning of March, when theRead More »…

Sanofi spends $425M to double down on Translate Bio mRNA pact, eyes Q4 COVID-19 vax start

  Sanofi Pasteur is betting big on its pact with mRNA biotech Translate Bio as it deepens its ties and commitment to infectious disease vaccines using this new tech. Read more. The post Sanofi spends $425M to double down on Translate Bio mRNA pact, eyes Q4 COVID-19 vax start appeared first on Atlas …

Nurturing A Culture Of “Smart Speed” To Bring Gene Therapy To The World

As we approach our 5th anniversary and surpass our 125th hire, we have come to recognize that one of the most important characteristics for success at AVROBIO is a commitment to our mantra of “smart speed.” We’ve been thinking a lot about what that term means for us – and for the field of gene thera…

Leading and Learning Through Challenging World Events

It’s been over three months since stay at home advisories and social distancing protocols abruptly arrived in Massachusetts. Calls for a return to normal and getting “back” to how things once were are growing louder by the day. In recent weeks, protests calling for racial equality and an end to syst…

Will Clinical Trials Make a House Call?

I love to travel. While still in training in internal medicine, I earned extra money to fund trips abroad by covering for community-based general practitioners (GPs). This usually involved staying in the GP’s house for the weekend, holding the cell phone and carrying a medical bag in what I call ‘th…

Atlas Venture Announces $400 Million Fund XII and Expansion of Partnership

Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly oversubscribed fundraise. With the closing of Fund XII, Michael Gladstone was promoted to partner. Atlas Venture…
Show more

Atlas Venture Frequently Asked Questions

  • When was Atlas Venture founded?

    Atlas Venture was founded in 1984.

  • Who are Atlas Venture key executives?

    Atlas Venture's key executives are Michael Gladstone, Lisa Huang and Andrea Dimella.

  • Where is Atlas Venture headquarters?

    Atlas Venture headquarters is located at 400 Technology Square, 400 Technology Square, Cambridge.

  • Where are Atlas Venture offices?

    Atlas Venture has an office in Cambridge.

  • How many offices does Atlas Venture have?

    Atlas Venture has 1 office.